DK1957121T3 - Akut behandling af social fobi med et androsta-4,16-dien-3-ol-steroid - Google Patents

Akut behandling af social fobi med et androsta-4,16-dien-3-ol-steroid

Info

Publication number
DK1957121T3
DK1957121T3 DK06803296.0T DK06803296T DK1957121T3 DK 1957121 T3 DK1957121 T3 DK 1957121T3 DK 06803296 T DK06803296 T DK 06803296T DK 1957121 T3 DK1957121 T3 DK 1957121T3
Authority
DK
Denmark
Prior art keywords
androsta
steroid
diene
social phobia
acute treatment
Prior art date
Application number
DK06803296.0T
Other languages
English (en)
Inventor
Louis Monti-Bloch
Original Assignee
Pherin Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pherin Pharm Inc filed Critical Pherin Pharm Inc
Application granted granted Critical
Publication of DK1957121T3 publication Critical patent/DK1957121T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/5685Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone having an oxo group in position 17, e.g. androsterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0043Nose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0097Micromachined devices; Microelectromechanical systems [MEMS]; Devices obtained by lithographic treatment of silicon; Devices comprising chips
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/06Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Otolaryngology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dispersion Chemistry (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
DK06803296.0T 2005-09-09 2006-09-08 Akut behandling af social fobi med et androsta-4,16-dien-3-ol-steroid DK1957121T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11/223,882 US8309539B2 (en) 2005-09-09 2005-09-09 Acute treatment of social phobia
PCT/US2006/035217 WO2007030800A2 (en) 2005-09-09 2006-09-08 Acute treatment of social phobia

Publications (1)

Publication Number Publication Date
DK1957121T3 true DK1957121T3 (da) 2013-03-18

Family

ID=37836566

Family Applications (1)

Application Number Title Priority Date Filing Date
DK06803296.0T DK1957121T3 (da) 2005-09-09 2006-09-08 Akut behandling af social fobi med et androsta-4,16-dien-3-ol-steroid

Country Status (12)

Country Link
US (2) US8309539B2 (da)
EP (1) EP1957121B1 (da)
JP (1) JP5143740B2 (da)
KR (1) KR101368003B1 (da)
CN (1) CN101304769B (da)
AU (1) AU2006287295B2 (da)
BR (1) BRPI0615786A2 (da)
CA (1) CA2621486C (da)
DK (1) DK1957121T3 (da)
ES (1) ES2398576T3 (da)
MX (1) MX2008003219A (da)
WO (1) WO2007030800A2 (da)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102007022916A1 (de) * 2007-05-14 2008-11-20 Henkel Ag & Co. Kgaa Pheromonhaltige kosmetische Mittel
CA3178758A1 (en) * 2020-05-18 2021-11-25 Shawn K. SINGH Treatment of adjustment disorders

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5969168A (en) 1991-01-07 1999-10-19 Pherin Corporation Androstanes for inducing hypothalamic effects
US5883087A (en) * 1991-01-07 1999-03-16 Pherin Corporation Androstane steroids as neurochemical initiators of change in human hypothalamic function and related pharmaceutical compositions and methods
US6066627A (en) * 1994-08-04 2000-05-23 Pherin Corporation Steroids as neurochemical initiators of change in human blood levels of LH
US6117860A (en) * 1994-08-04 2000-09-12 Pherin Pharmaceuticals, Inc. Steroids as neurochemical stimulators of the VNO to treat paroxistic tachycardia
BR9711812A (pt) * 1996-07-23 1999-08-24 Pherin Pharm Inc EsterÄides como estimuladores neuroqu¡micos do ÄrgÆo vomeronasal para aliviar os sintomas de pms e ansiedade
US6225057B1 (en) * 1998-07-23 2001-05-01 Palleja, Zavier Estivell Duplications of human chromosome 15q24-25 and anxiety disorders, diagnostic methods for their detection

Also Published As

Publication number Publication date
EP1957121A2 (en) 2008-08-20
US8309539B2 (en) 2012-11-13
CA2621486C (en) 2013-11-12
US20070059249A1 (en) 2007-03-15
US20130172305A1 (en) 2013-07-04
CN101304769A (zh) 2008-11-12
JP2009507832A (ja) 2009-02-26
WO2007030800A3 (en) 2007-10-11
BRPI0615786A2 (pt) 2011-05-24
CA2621486A1 (en) 2007-03-15
AU2006287295B2 (en) 2012-07-05
KR101368003B1 (ko) 2014-03-14
EP1957121A4 (en) 2010-07-07
KR20080044338A (ko) 2008-05-20
CN101304769B (zh) 2012-11-21
US8722652B2 (en) 2014-05-13
AU2006287295A1 (en) 2007-03-15
JP5143740B2 (ja) 2013-02-13
WO2007030800A2 (en) 2007-03-15
EP1957121B1 (en) 2012-12-12
MX2008003219A (es) 2008-03-18
ES2398576T3 (es) 2013-03-20

Similar Documents

Publication Publication Date Title
BRPI0921117A2 (pt) processo de montagem de uma peça inserida, dispositivo de fixação intermediária, vidraça e utilização do dispositivo de fixação intermediária.
ES2355534T8 (es) Derivados de isoquinolina e isoquinolinona sustituidos con cicloalquilamina.
DK3363415T3 (da) Fragmentering af væv med krum fotonedbrydende laser
DK2982696T3 (da) Behandling af akut lymfoblastær leukæmi
DK1880574T3 (da) Høresystem med forbedret højfrekvensrespons
DE602007001105D1 (de) Hartstofffilm und Herstellungsverfahren dafür
DK3399667T3 (da) Forhindring af selvinduceret interferens i anordning med dobbelt radio
BRPI0819980A2 (pt) Conjunto e método de sutura
DK2068874T3 (da) Fremgangsmåder til behandling af multiple myelom med anvendelse af kombinationsterapier baseret på anti-cs1 antistoffer
BRPI0809663A2 (pt) Composição de vírus vivo atenuado, método de diminuição da inativação de composição de vírus vivo atenuado e kit respectivo
DE112007000789A5 (de) Verwendung von Bora-tetraazepentalenen
BRPI0820139A2 (pt) Composição antiperspirante ativa, e, processo de obtenção de uma composição antiperspirante ativa
DK2099453T3 (da) Kombinationsterapi med substituerede oxazolidinoner
BRPI0820507A2 (pt) dispositivos, disposições e métodos de concentração e refrigeração solar
DK1776136T3 (da) Behandling af tilstande, der involverer demyelinisering
BR112012000735A2 (pt) "métodos, kits e conjuntos de compostos"
BRPI0809573A2 (pt) composição, e, método
BRPI0818111A2 (pt) Processo de gerenciamento dos efluentes térmicos de uma aernave, dispositivo de resfriamento de uma aeronave e aeronave.
DE602008002133D1 (de) Schlafbewertungsvorrichtung und Schlafbewertungsverfahren dafür
DE602006018715D1 (de) Entzerrerschaltung und Methode
DK2023994T3 (da) Kateter med en aflang slids
BRPI0719250A2 (pt) Métodos e composições com opalescência reduzida.
DK1981506T6 (da) Langtidsbehandling af hiv-infektion med tcm278
BRPI0912350A2 (pt) circuito de interface, e, interface
BRPI0814167A2 (pt) Composição, e, método